Jamil B Alkhaddo, MD
Endocrinology · Carlsbad
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Office
- 1
- Since medical school
- 24 years
- Graduated 2002
Offices
1 location · Tri-City Primary Care Medical Group Inc · 8 clinicians in this group
Hospitals listed: Tri-City Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Alkhaddo’s office at (760) 940-7000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C186416 · Current
Licensed to practise in California · since 2023 · expires 2027-05-31 · University of Aleppo Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Tri-City Medical CenterOceanside, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPart of Tri City Healthcare DistrictPatients rate it 2 of 5 · 52% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
See every measure and the patient survey for Tri-City Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.39 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 536 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.56 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.5 (123.11 to 247.89) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 109 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 156 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.1 · 255 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 15.6 · 251 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.4 · 2,347 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 3,248 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.08 to 0.49) · 3,281 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3 (0.72 to 5.29) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.53 (0 to 3.19) · 279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.93 (0.35 to 3.5) · 743 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.69 (1.61 to 17.78) · 289 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.31 (1.29 to 9.34) · 268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 176 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0 to 1.35) · 2,305 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.9 · 59 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.052 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.974 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.103 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.522 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 215 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.7 · 298 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -7.8 · 116 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 29.1 · 191 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 14 · 287 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 447 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.6 (3.5 to 8.9) · 32 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (7.2 to 15.6) · 32 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.8 · 62 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 31 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 172 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.4 to 17.5) · 36 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 257 cases | No different | Jan 2024 – Dec 2024 |
What patients said (403 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 79% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 53% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 39% |
| "YES", patients would definitely recommend the hospital | 52% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$61,382
Medicare paid this office $61,382 for 244 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 21 | $22,479 | None |
| Return visit (30+ min) | 84 | $11,936 | $109 |
| New patient visit (45+ min) | 80 | $10,474 | $131 |
| Short return visit (20+ min) | 77 | $6,463 | $76 |
| New patient visit (30+ min) | 52 | $4,743 | $91 |
See all 7 services
| Injection, denosumab, 1 mg | 21 | $22,479 | None |
| Return visit (30+ min) | 84 | $11,936 | $109 |
| New patient visit (45+ min) | 80 | $10,474 | $131 |
| Short return visit (20+ min) | 77 | $6,463 | $76 |
| New patient visit (30+ min) | 52 | $4,743 | $91 |
| Injection of drug or substance under skin or into muscle | 22 | $395 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 16 | $224 | $14 |
Who their Medicare patients are
244 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 14% · Women 67% · Also on Medicaid 18% · Health risk score 1.48. Above the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 45% · Chronic kidney disease 34% · Coronary heart disease 32% · Depression 21% · Atrial fibrillation 19% · Heart failure 18% · Cancer 14% · Stroke 13% · COPD 11% · Dementia 6%.
The office billed $247,233, Medicare allowed $81,493 and paid $61,382; for 1,814 services of 18 kinds; $24,324 of it was for drugs given in the office and $37,058 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 244 | 1,814 | 74 | 1.48 | $247,233 | $61,382 |
| 2023 | 159 | 217 | 71 | 1.45 | $69,386 | $14,680 |
| 2022 | 245 | 391 | 71 | 1.33 | $127,842 | $29,948 |
| 2021 | 190 | 322 | 71 | 1.60 | $95,703 | $24,011 |
| 2020 | 245 | 390 | 70 | 1.74 | $99,305 | $24,445 |
| 2019 | 211 | 400 | 70 | 1.88 | $108,730 | $31,321 |
| 2018 | 189 | 406 | 68 | 1.51 | $97,593 | $27,950 |
| 2017 | 222 | 467 | 69 | 1.85 | $111,749 | $31,476 |
| 2016 | 173 | 456 | 68 | 1.98 | $98,493 | $29,567 |
| 2015 | 34 | 70 | 67 | 1.49 | $16,122 | $5,372 |
| 2013 | 135 | 313 | 73 | 2.31 | $94,383 | $27,713 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 83 | $7,769 | $78 |
| Short return visit (20+ min) | 69 | $3,901 | $55 |
| New patient visit (30+ min) | 11 | $980 | $89 |
2022: 3 services
| Return visit (30+ min) | 171 | $20,399 | $85 |
| Short return visit (20+ min) | 60 | $4,089 | $61 |
| New patient visit (45+ min) | 13 | $1,515 | $117 |
2021: 6 services
| Return visit (30+ min) | 85 | $9,896 | $90 |
| Short return visit (20+ min) | 57 | $3,755 | $60 |
| New patient visit (45+ min) | 23 | $2,872 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,168 | $57 |
| New patient visit (30+ min) | 12 | $962 | $80 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $885 | $31 |
2020: 7 services
| Return visit (30+ min) | 112 | $9,394 | $71 |
| New patient visit (45+ min) | 38 | $3,958 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $2,326 | $58 |
| Short return visit (20+ min) | 23 | $1,139 | $46 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $924 | $77 |
| Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | 12 | $718 | $30 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $638 | $32 |
2019: 6 services
| Return visit (30+ min) | 134 | $12,926 | $74 |
| Long return visit (40+ min) | 53 | $6,347 | $102 |
| New patient visit (45+ min) | 24 | $3,058 | $127 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,845 | $109 |
| New patient visit (60+ min) | 12 | $1,611 | $134 |
| Hemoglobin a1c level | 31 | $359 | $11 |
2018: 7 services
| Return visit (30+ min) | 80 | $8,411 | $72 |
| Long return visit (40+ min) | 34 | $4,719 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $4,298 | $57 |
| New patient visit (45+ min) | 26 | $2,687 | $103 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,043 | $108 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $617 | $31 |
| Hemoglobin a1c level | 18 | $235 | $12 |
2017: 8 services
| Return visit (30+ min) | 87 | $7,947 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,574 | $56 |
| Long return visit (40+ min) | 39 | $3,704 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 37 | $3,646 | $99 |
| New patient visit (45+ min) | 28 | $2,808 | $100 |
| Diabetes outpatient self-management training services, individual, per 30 minutes | 12 | $912 | $41 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 19 | $829 | $31 |
| Hemoglobin a1c level | 16 | $261 | $13 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $6,130 | $55 |
| Long return visit (40+ min) | 33 | $4,440 | $99 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,350 | $101 |
| Return visit (30+ min) | 39 | $3,630 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,154 | $154 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $1,817 | $79 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,168 | $30 |
| New patient visit (45+ min) | 12 | $1,113 | $93 |
2015: 1 service
| Return visit (30+ min) | 15 | $1,633 | $82 |
2013: 9 services
| Critical care, first 30-74 minutes | 23 | $4,433 | $170 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,426 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $4,149 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,001 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,873 | $80 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,648 | $82 |
| Initial hospital observation care per day, typically 50 minutes | 13 | $1,443 | $103 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,057 | $56 |
| Follow-up observation care per day, typically 25 minutes | 11 | $682 | $52 |
Drugs they prescribed that Part D paid
$616,710
Pharmacies billed $616,710 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,355) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
615 generic and 651 brand-name prescriptions · $616,710 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 110 | $146,616 | $1,333 |
| Mounjaro | 92 | $110,750 | $1,204 |
| Jardiance | 56 | $69,766 | $1,246 |
| Trulicity | 39 | $57,597 | $1,477 |
| Forteo | 12 | $38,443 | $3,204 |
See all 27 drugs
| Ozempic | 110 | $146,616 | $1,333 |
| Mounjaro | 92 | $110,750 | $1,204 |
| Jardiance | 56 | $69,766 | $1,246 |
| Trulicity | 39 | $57,597 | $1,477 |
| Forteo | 12 | $38,443 | $3,204 |
| Rybelsus | 28 | $35,944 | $1,284 |
| Humalog Kwikpen U-100 | 33 | $8,038 | $244 |
| Lantus Solostar | 53 | $6,514 | $123 |
| Basaglar Kwikpen U-100 | 19 | $5,781 | $304 |
| Nano 2nd Gen Pen Needle | 47 | $3,680 | $78 |
| Synthroid | 43 | $2,878 | $67 |
| Novolog Flexpen | 15 | $2,619 | $175 |
| Levothyroxine | 150 | $1,775 | $12 |
| Repaglinide | 38 | $1,539 | $41 |
| Pioglitazone | 94 | $1,241 | $13 |
| Testosterone | 15 | $1,211 | $81 |
| Hydrocortisone | 22 | $807 | $37 |
| Topiramate | 19 | $692 | $36 |
| Liothyronine | 26 | $634 | $24 |
| Methimazole | 39 | $397 | $10 |
| Metformin | 31 | $370 | $12 |
| Metformin Hcl Er | 35 | $330 | $9 |
| Alendronate | 20 | $295 | $15 |
| Glipizide Er | 19 | $188 | $10 |
| Rosuvastatin | 24 | $151 | $6 |
| Glipizide | 14 | $137 | $10 |
| Atorvastatin | 21 | $100 | $5 |
Year by year
| 2024 | 1,355 | 411 | 0% (0) | 48% | $616,710 |
| 2023 | 2,314 | 329 | 0% (0) | 42% | $1,052,293 |
| 2022 | 2,969 | 431 | 0% (0) | 42% | $1,246,940 |
| 2021 | 2,528 | 386 | 0% (0) | 41% | $899,492 |
| 2020 | 3,030 | 443 | 0% (0) | 45% | $1,122,504 |
| 2019 | 2,690 | 386 | 0% (0) | 46% | $940,954 |
| 2018 | 1,886 | 280 | 0% (0) | 48% | $599,581 |
| 2017 | 1,657 | 247 | 0% (0) | 47% | $446,340 |
| 2016 | 925 | 132 | 0% (0) | 49% | $256,583 |
| 2015 | 280 | 62 | 0% (0) | 51% | $66,112 |
| 2014 | 76 | 15 | None | None | $6,112 |
| 2013 | 118 | 38 | None | 29% | $6,297 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Trulicity | 164 | $268,893 | $1,640 |
| Ozempic | 87 | $138,658 | $1,594 |
| Jardiance | 94 | $114,819 | $1,221 |
| Mounjaro | 58 | $79,828 | $1,376 |
| Novolog Flexpen | 40 | $63,797 | $1,595 |
| Forteo | 12 | $53,980 | $4,498 |
| Lantus Solostar | 45 | $26,596 | $591 |
| Farxiga | 20 | $22,997 | $1,150 |
| Humalog Kwikpen U-100 | 12 | $18,322 | $1,527 |
| Tresiba Flextouch U-100 | 21 | $17,170 | $818 |
| Omnipod 5 G6 Pods (Gen 5) | 21 | $16,666 | $794 |
| Novolog | 14 | $15,530 | $1,109 |
| Levemir Flexpen | 13 | $13,817 | $1,063 |
| Basaglar Kwikpen U-100 | 25 | $12,755 | $510 |
| Synthroid | 170 | $10,673 | $63 |
| Humulin R U-500 Kwikpen | 12 | $9,219 | $768 |
| Levothyroxine | 455 | $7,546 | $17 |
| Cinacalcet | 11 | $5,828 | $530 |
| Nano 2nd Gen Pen Needle | 23 | $4,107 | $179 |
| Testosterone | 17 | $3,711 | $218 |
| Icosapent Ethyl | 19 | $2,612 | $137 |
| Hydrocortisone | 47 | $2,168 | $46 |
| Rosuvastatin | 86 | $1,736 | $20 |
| Metformin Hcl Er | 77 | $1,592 | $21 |
| Pioglitazone | 77 | $1,020 | $13 |
| Liothyronine | 32 | $974 | $30 |
| Metformin | 79 | $870 | $11 |
| Repaglinide | 33 | $860 | $26 |
| Atorvastatin | 41 | $640 | $16 |
| Ultra-Fine Mini Pen Needle | 13 | $590 | $45 |
| Fludrocortisone Acetate | 15 | $512 | $34 |
| Glipizide Er | 33 | $462 | $14 |
| Methimazole | 40 | $435 | $11 |
| Glimepiride | 41 | $364 | $9 |
| Alendronate | 23 | $230 | $10 |
| Lisinopril | 24 | $166 | $7 |
2022: 45 drugs
| Trulicity | 191 | $299,502 | $1,568 |
| Jardiance | 145 | $158,511 | $1,093 |
| Ozempic | 108 | $149,444 | $1,384 |
| Novolog Flexpen | 69 | $115,609 | $1,675 |
| Forteo | 15 | $64,271 | $4,285 |
| Farxiga | 54 | $48,386 | $896 |
| Tresiba Flextouch U-100 | 45 | $39,988 | $889 |
| Victoza 3-Pak | 14 | $34,887 | $2,492 |
| Tresiba Flextouch U-200 | 12 | $25,184 | $2,099 |
| Levemir Flextouch | 28 | $22,020 | $786 |
| Basaglar Kwikpen U-100 | 42 | $21,762 | $518 |
| Lantus Solostar | 44 | $20,099 | $457 |
| Humalog Kwikpen U-100 | 18 | $16,748 | $930 |
| Synthroid | 209 | $13,071 | $63 |
| Tradjenta | 14 | $11,382 | $813 |
| Toujeo Solostar | 12 | $8,974 | $748 |
| Levothyroxine | 535 | $8,822 | $16 |
| Insulin Lispro Kwikpen U-100 | 21 | $4,543 | $216 |
| Nano 2nd Gen Pen Needle | 30 | $4,304 | $143 |
| Ultra-Fine Short Pen Needle | 15 | $2,917 | $194 |
| Hydrocortisone | 59 | $2,640 | $45 |
| Icosapent Ethyl | 13 | $2,170 | $167 |
| Metformin Hcl Er | 141 | $2,061 | $15 |
| Sure Comfort Pen Needle | 24 | $1,942 | $81 |
| Repaglinide | 60 | $1,747 | $29 |
| Rosuvastatin | 76 | $1,733 | $23 |
| Liothyronine | 50 | $1,515 | $30 |
| Ultra-Fine Mini Pen Needle | 14 | $1,277 | $91 |
| Ezetimibe | 18 | $1,124 | $62 |
| Metformin | 130 | $1,075 | $8 |
| Ultra-Fine Nano Pen Needle | 13 | $944 | $73 |
| Glimepiride | 54 | $886 | $16 |
| Alendronate | 55 | $695 | $13 |
| Methimazole | 75 | $692 | $9 |
| Atorvastatin | 53 | $619 | $12 |
| Fludrocortisone Acetate | 16 | $521 | $33 |
| Glipizide Er | 19 | $373 | $20 |
| Simvastatin | 25 | $227 | $9 |
| Gabapentin | 14 | $195 | $14 |
| Pravastatin | 11 | $195 | $18 |
| Glipizide | 25 | $193 | $8 |
| Lisinopril | 28 | $173 | $6 |
| Enalapril Maleate | 11 | $163 | $15 |
| Prednisone | 17 | $117 | $7 |
| Valsartan | 11 | $81 | $7 |
2021: 44 drugs
| Trulicity | 152 | $223,620 | $1,471 |
| Jardiance | 90 | $103,915 | $1,155 |
| Novolog Flexpen | 55 | $80,363 | $1,461 |
| Ozempic | 49 | $56,037 | $1,144 |
| Victoza 3-Pak | 28 | $46,448 | $1,659 |
| Humalog Kwikpen U-100 | 30 | $44,405 | $1,480 |
| Tresiba Flextouch U-100 | 43 | $36,068 | $839 |
| Tresiba Flextouch U-200 | 13 | $25,078 | $1,929 |
| Basaglar Kwikpen U-100 | 51 | $22,499 | $441 |
| Januvia | 25 | $19,121 | $765 |
| Farxiga | 14 | $17,563 | $1,255 |
| Lantus Solostar | 45 | $17,077 | $379 |
| Tradjenta | 20 | $16,438 | $822 |
| Novolog | 12 | $14,371 | $1,198 |
| Levemir Flextouch | 17 | $11,346 | $667 |
| Synthroid | 158 | $10,396 | $66 |
| Levothyroxine | 423 | $8,024 | $19 |
| Xyosted | 11 | $5,970 | $543 |
| Testosterone | 12 | $5,302 | $442 |
| Hydrocortisone | 63 | $2,262 | $36 |
| Nano 2nd Gen Pen Needle | 12 | $2,254 | $188 |
| Metformin Hcl Er | 126 | $1,618 | $13 |
| Ultra-Fine Mini Pen Needle | 24 | $1,548 | $64 |
| Pen Needles | 17 | $1,447 | $85 |
| Rosuvastatin | 64 | $1,417 | $22 |
| Liothyronine | 46 | $1,392 | $30 |
| Armour Thyroid | 11 | $1,231 | $112 |
| Repaglinide | 33 | $1,078 | $33 |
| Ultra-Fine Nano Pen Needle | 12 | $924 | $77 |
| Fenofibrate | 13 | $781 | $60 |
| Atorvastatin | 69 | $754 | $11 |
| Glimepiride | 55 | $716 | $13 |
| Metformin | 95 | $695 | $7 |
| Methimazole | 103 | $686 | $7 |
| Alendronate | 70 | $655 | $9 |
| Gabapentin | 21 | $471 | $22 |
| Ezetimibe | 11 | $406 | $37 |
| Fludrocortisone Acetate | 18 | $369 | $20 |
| Lisinopril | 30 | $293 | $10 |
| Pravastatin | 22 | $280 | $13 |
| Glipizide Er | 33 | $234 | $7 |
| Glipizide | 23 | $198 | $9 |
| Simvastatin | 25 | $195 | $8 |
| Losartan | 23 | $149 | $6 |
2020: 51 drugs
| Trulicity | 212 | $272,653 | $1,286 |
| Victoza 3-Pak | 51 | $98,742 | $1,936 |
| Jardiance | 105 | $96,244 | $917 |
| Novolog Flexpen | 65 | $89,234 | $1,373 |
| Humalog Kwikpen U-100 | 63 | $65,922 | $1,046 |
| Tresiba Flextouch U-100 | 53 | $40,243 | $759 |
| Lantus Solostar | 71 | $39,552 | $557 |
| Tresiba Flextouch U-200 | 21 | $29,992 | $1,428 |
| Farxiga | 19 | $26,484 | $1,394 |
| Novolog | 28 | $25,377 | $906 |
| Basaglar Kwikpen U-100 | 66 | $25,355 | $384 |
| Toujeo Max Solostar | 11 | $24,783 | $2,253 |
| Toujeo Solostar | 26 | $22,621 | $870 |
| Tradjenta | 34 | $22,298 | $656 |
| Sensipar | 13 | $18,770 | $1,444 |
| Ozempic | 18 | $17,701 | $983 |
| Januvia | 20 | $15,854 | $793 |
| Levemir Flextouch | 15 | $11,793 | $786 |
| Synthroid | 164 | $10,940 | $67 |
| Humalog | 13 | $10,391 | $799 |
| Levothyroxine | 425 | $9,222 | $22 |
| Repaglinide | 76 | $3,064 | $40 |
| Ultra-Fine Short Pen Needle | 18 | $2,474 | $137 |
| Rosuvastatin | 70 | $2,377 | $34 |
| Ultra-Fine Nano Pen Needle | 20 | $2,336 | $117 |
| Hydrocortisone | 65 | $2,212 | $34 |
| Nano 2nd Gen Pen Needle | 22 | $2,124 | $97 |
| Metformin Hcl Er | 126 | $1,904 | $15 |
| Pen Needles | 26 | $1,890 | $73 |
| Novolin 70-30 | 14 | $1,791 | $128 |
| Liothyronine | 25 | $1,336 | $53 |
| Ultra-Fine Mini Pen Needle | 27 | $1,331 | $49 |
| Atorvastatin | 87 | $1,308 | $15 |
| Glimepiride | 82 | $1,229 | $15 |
| Metformin | 151 | $1,197 | $8 |
| Fenofibrate | 13 | $1,092 | $84 |
| Ulticare Pen Needle | 12 | $611 | $51 |
| Methimazole | 75 | $538 | $7 |
| Pravastatin | 33 | $525 | $16 |
| Glipizide Er | 57 | $513 | $9 |
| Alendronate | 52 | $443 | $9 |
| Losartan | 32 | $438 | $14 |
| Pioglitazone | 19 | $425 | $22 |
| Gabapentin | 14 | $407 | $29 |
| Lisinopril | 35 | $389 | $11 |
| Fludrocortisone Acetate | 12 | $248 | $21 |
| Glipizide | 14 | $178 | $13 |
| Testosterone Cypionate | 12 | $169 | $14 |
| Simvastatin | 22 | $157 | $7 |
| Amlodipine Besylate | 15 | $61 | $4 |
| Prednisone | 12 | $54 | $4 |
2019: 49 drugs
| Trulicity | 151 | $155,141 | $1,027 |
| Novolog Flexpen | 68 | $98,920 | $1,455 |
| Victoza 3-Pak | 40 | $78,829 | $1,971 |
| Humalog Kwikpen U-100 | 54 | $66,448 | $1,231 |
| Jardiance | 61 | $54,704 | $897 |
| Lantus Solostar | 61 | $43,582 | $714 |
| Tresiba Flextouch U-100 | 55 | $34,716 | $631 |
| Tresiba Flextouch U-200 | 27 | $29,630 | $1,097 |
| Toujeo Solostar | 34 | $28,144 | $828 |
| Farxiga | 16 | $22,462 | $1,404 |
| Novolog | 26 | $21,215 | $816 |
| Ozempic | 16 | $20,897 | $1,306 |
| Basaglar Kwikpen U-100 | 45 | $20,480 | $455 |
| Sensipar | 13 | $18,853 | $1,450 |
| Victoza 2-Pak | 19 | $17,766 | $935 |
| Levemir Flextouch | 20 | $15,267 | $763 |
| Tradjenta | 18 | $13,656 | $759 |
| Bydureon | 11 | $10,154 | $923 |
| Synthroid | 180 | $9,795 | $54 |
| Testosterone | 20 | $8,873 | $444 |
| Januvia | 11 | $8,629 | $784 |
| Levothyroxine | 361 | $7,588 | $21 |
| Humalog | 11 | $5,823 | $529 |
| Lantus | 15 | $5,299 | $353 |
| Repaglinide | 87 | $3,839 | $44 |
| Ultra-Fine Nano Pen Needle | 30 | $2,514 | $84 |
| Ultra-Fine Short Pen Needle | 19 | $2,169 | $114 |
| Tirosint | 11 | $1,793 | $163 |
| Pen Needles | 23 | $1,774 | $77 |
| Metformin Hcl Er | 99 | $1,671 | $17 |
| Ultra-Fine Mini Pen Needle | 28 | $1,651 | $59 |
| Rosuvastatin | 44 | $1,630 | $37 |
| Atorvastatin | 87 | $1,367 | $16 |
| Metformin | 163 | $1,287 | $8 |
| Glipizide Er | 58 | $1,286 | $22 |
| Hydrocortisone | 26 | $1,098 | $42 |
| Novolin 70-30 | 11 | $846 | $77 |
| Glimepiride | 54 | $811 | $15 |
| Pravastatin | 39 | $792 | $20 |
| Methimazole | 70 | $726 | $10 |
| Gabapentin | 13 | $505 | $39 |
| Losartan | 46 | $496 | $11 |
| Lisinopril | 44 | $392 | $9 |
| Glipizide | 22 | $255 | $12 |
| Felodipine Er | 13 | $181 | $14 |
| Simvastatin | 16 | $179 | $11 |
| Alendronate | 17 | $165 | $10 |
| Amlodipine Besylate | 26 | $123 | $5 |
| Carvedilol | 14 | $69 | $5 |
2018: 44 drugs
| Trulicity | 116 | $106,828 | $921 |
| Victoza 3-Pak | 33 | $62,562 | $1,896 |
| Novolog Flexpen | 42 | $51,694 | $1,231 |
| Humalog Kwikpen U-100 | 51 | $47,424 | $930 |
| Lantus Solostar | 63 | $33,730 | $535 |
| Tresiba Flextouch U-100 | 38 | $24,293 | $639 |
| Toujeo Solostar | 29 | $20,868 | $720 |
| Novolog Mix 70-30 Flexpen | 15 | $19,298 | $1,287 |
| Tresiba Flextouch U-200 | 21 | $18,670 | $889 |
| Lyrica | 18 | $15,436 | $858 |
| Invokana | 19 | $15,354 | $808 |
| Januvia | 14 | $12,698 | $907 |
| Jardiance | 14 | $12,144 | $867 |
| Basaglar Kwikpen U-100 | 19 | $8,326 | $438 |
| Levemir Flextouch | 15 | $7,263 | $484 |
| Synthroid | 138 | $7,207 | $52 |
| Humalog | 13 | $6,513 | $501 |
| Testosterone | 11 | $5,761 | $524 |
| Levothyroxine | 233 | $5,201 | $22 |
| Lantus | 13 | $3,973 | $306 |
| Repaglinide | 47 | $2,613 | $56 |
| Novolin 70-30 | 14 | $2,504 | $179 |
| Ultra-Fine Mini Pen Needle | 40 | $2,017 | $50 |
| Ultra-Fine Nano Pen Needle | 29 | $1,813 | $63 |
| Ultra-Fine Short Pen Needle | 21 | $1,746 | $83 |
| Hydrocortisone | 36 | $1,224 | $34 |
| Metformin | 122 | $1,122 | $9 |
| Atorvastatin | 37 | $752 | $20 |
| Rosuvastatin | 30 | $745 | $25 |
| Cabergoline | 11 | $726 | $66 |
| Metformin Hcl Er | 58 | $679 | $12 |
| Glipizide Er | 26 | $630 | $24 |
| Glimepiride | 30 | $613 | $20 |
| Pravastatin | 20 | $474 | $24 |
| Liothyronine | 12 | $449 | $37 |
| Methimazole | 36 | $352 | $10 |
| Glipizide Xl | 31 | $323 | $10 |
| Fludrocortisone Acetate | 11 | $307 | $28 |
| Alendronate | 29 | $262 | $9 |
| Lisinopril | 20 | $228 | $11 |
| Felodipine Er | 13 | $191 | $15 |
| Losartan | 21 | $144 | $7 |
| Glipizide | 12 | $140 | $12 |
| Hydrochlorothiazide | 12 | $42 | $4 |
2017: 42 drugs
| Trulicity | 65 | $53,891 | $829 |
| Victoza 3-Pak | 32 | $41,431 | $1,295 |
| Humalog Kwikpen U-100 | 39 | $40,299 | $1,033 |
| Novolog Flexpen | 34 | $39,890 | $1,173 |
| Lantus Solostar | 50 | $26,376 | $528 |
| Toujeo Solostar | 30 | $22,829 | $761 |
| Januvia | 36 | $20,657 | $574 |
| Invokana | 19 | $17,199 | $905 |
| Androgel | 11 | $14,644 | $1,331 |
| Tresiba Flextouch U-200 | 11 | $13,553 | $1,232 |
| Tresiba Flextouch U-100 | 26 | $12,131 | $467 |
| Tradjenta | 24 | $12,118 | $505 |
| Levemir Flextouch | 24 | $9,423 | $393 |
| Tanzeum | 17 | $8,905 | $524 |
| Novolog | 16 | $8,116 | $507 |
| Lantus | 22 | $7,095 | $323 |
| Levemir | 12 | $6,309 | $526 |
| Synthroid | 100 | $4,577 | $46 |
| Levothyroxine | 216 | $4,103 | $19 |
| Alcohol Prep Pads | 12 | $1,689 | $141 |
| Novolin 70-30 | 12 | $1,637 | $136 |
| Ultra-Fine Nano Pen Needle | 24 | $1,494 | $62 |
| Tirosint | 12 | $1,468 | $122 |
| Rosuvastatin | 22 | $1,352 | $61 |
| Glipizide Er | 56 | $1,132 | $20 |
| Ultra-Fine Mini Pen Needle | 19 | $922 | $49 |
| Metformin | 104 | $819 | $8 |
| Hydrocortisone | 13 | $696 | $54 |
| Glimepiride | 46 | $633 | $14 |
| Metformin Hcl Er | 64 | $614 | $10 |
| Ultra-Fine Short Pen Needle | 14 | $586 | $42 |
| Repaglinide | 11 | $549 | $50 |
| Pravastatin | 34 | $504 | $15 |
| Atorvastatin | 37 | $427 | $12 |
| Pioglitazone | 12 | $417 | $35 |
| Methimazole | 22 | $317 | $14 |
| Glipizide Xl | 29 | $316 | $11 |
| Fludrocortisone Acetate | 11 | $186 | $17 |
| Alendronate | 18 | $165 | $9 |
| Lisinopril | 20 | $137 | $7 |
| Glipizide | 16 | $66 | $4 |
| Amlodipine Besylate | 11 | $39 | $4 |
2016: 21 drugs
| Lantus Solostar | 78 | $45,944 | $589 |
| Humalog Kwikpen U-100 | 31 | $34,901 | $1,126 |
| Victoza 3-Pak | 30 | $31,972 | $1,066 |
| Novolog Flexpen | 27 | $20,633 | $764 |
| Invokana | 26 | $14,098 | $542 |
| Tresiba Flextouch U-200 | 13 | $12,013 | $924 |
| Levemir Flextouch | 20 | $7,828 | $391 |
| Tradjenta | 14 | $7,671 | $548 |
| Novolog | 14 | $5,545 | $396 |
| Metformin Hcl Er | 61 | $2,708 | $44 |
| Synthroid | 45 | $2,003 | $45 |
| Bd Ultra-Fine Pen Needle | 37 | $1,987 | $54 |
| Levothyroxine | 86 | $1,683 | $20 |
| Rosuvastatin | 11 | $953 | $87 |
| Glipizide Er | 36 | $747 | $21 |
| Metformin | 59 | $535 | $9 |
| Pravastatin | 23 | $364 | $16 |
| Methimazole | 23 | $316 | $14 |
| Glimepiride | 14 | $282 | $20 |
| Atorvastatin | 18 | $117 | $6 |
| Alendronate | 15 | $90 | $6 |
2015: 8 drugs
| Novolog Flexpen | 19 | $13,683 | $720 |
| Lantus Solostar | 23 | $11,817 | $514 |
| Invokana | 22 | $10,601 | $482 |
| Synthroid | 17 | $542 | $32 |
| Levothyroxine | 26 | $390 | $15 |
| Atorvastatin | 12 | $162 | $14 |
| Metformin Hcl Er | 15 | $111 | $7 |
| Metformin | 13 | $79 | $6 |
2014: 2 drugs
| Levothyroxine | 24 | $274 | $11 |
| Metoprolol | 20 | $60 | $3 |
2013: 2 drugs
| Levothyroxine | 24 | $160 | $7 |
| Metoprolol | 23 | $105 | $5 |
Money from drug and device companies
$1,538 in 2025
| 2025 | 20 | 61 | None | $1,538 |
| 2024 | 12 | 47 | None | $1,066 |
| 2023 | 14 | 36 | None | $1,047 |
| 2022 | 10 | 21 | None | $630 |
| 2021 | 3 | 11 | None | $170 |
| 2020 | 2 | 2 | None | $46 |
| 2019 | 4 | 6 | None | $209 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Beta Bionics | Ilet Bionic Pancreas | $257 | 4 payments
|
| CeQur | Cequr Simplicity | $178 | 1 payment
|
| Xeris Pharmaceuticals | Recorlev | $162 | 9 payments
|
| Amgen | Tepezza | $155 | 6 payments
|
| Abiomed | None | $150 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $81 | 4 payments
|
See all 54 published payments
| Xeris Pharmaceuticals | Meals · 2025-12-22 | Recorlev | $7 |
| Corcept Therapeutics | Meals · 2025-12-17 | Korlym | $23 |
| Dexcom | Meals · 2025-12-15 | Dexcom G6 Transmitter | $13 |
| Amgen | Meals · 2025-12-10 | Tepezza | $25 |
| Sanofi-Aventis U.S. | Meals · 2025-12-10 | Tzield | $15 |
| Intra-Sana Laboratories | Meals · 2025-12-08 | Reltone 200 Mg | $16 |
| Corcept Therapeutics | Meals · 2025-12-05 | Korlym | $24 |
| Medtronic | Meals · 2025-12-03 | Minimed 780g | $19 |
| Xeris Pharmaceuticals | Meals · 2025-12-03 | Gvoke Hypopen | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-02 | Caplyta | $33 |
| Tandem Diabetes Care | Meals · 2025-11-13 | T:Slim X2 Insulin Pump With Control-Iq | $5 |
| Mannkind | Education · 2025-11-13 | Afrezza | $43 |
| Mannkind | Meals · 2025-11-12 | Afrezza | $17 |
| Sequel Med Tech | Meals · 2025-10-29 | Twiist | $18 |
| Radius Health | Meals · 2025-10-24 | None | $27 |
| Tandem Diabetes Care | Meals · 2025-10-22 | T:Slim X2 Insulin Pump With Control-Iq | $24 |
| Amgen | Meals · 2025-10-17 | Evenity | $17 |
| Corcept Therapeutics | Meals · 2025-10-15 | Korlym | $14 |
| Xeris Pharmaceuticals | Meals · 2025-10-08 | Gvoke Hypopen | $24 |
| Dexcom | Meals · 2025-10-08 | Dexcom G6 Transmitter | $22 |
| Insulet | Meals · 2025-10-03 | Omnipod | $19 |
| Xeris Pharmaceuticals | Meals · 2025-10-02 | Recorlev | $11 |
| Beta Bionics | Meals · 2025-09-17 | Ilet Bionic Pancreas | $11 |
| Ascensia Diabetes Care Us | Meals · 2025-09-05 | None | $19 |
| Amgen | Meals · 2025-09-05 | Tepezza | $29 |
| Abbott Laboratories | Meals · 2025-09-04 | Freestyle Libre 3 | $27 |
| Xeris Pharmaceuticals | Meals · 2025-08-29 | Recorlev | $22 |
| Intra-Sana Laboratories | Meals · 2025-08-13 | Reltone 200 Mg | $15 |
| Tandem Diabetes Care | Meals · 2025-07-29 | T:Slim X2 Insulin Pump With Control-Iq | $17 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-25 | Kerendia | $14 |
| Sanofi-Aventis U.S. | Meals · 2025-07-25 | Tzield | $18 |
| Lilly USA | Meals · 2025-07-22 | Mounjaro | $22 |
| Amgen | Meals · 2025-07-18 | Tepezza | $28 |
| Xeris Pharmaceuticals | Meals · 2025-07-08 | Recorlev | $23 |
| Abbott Laboratories | Meals · 2025-06-26 | Freestyle Libre 3 | $23 |
| Beta Bionics | Meals · 2025-05-23 | Ilet Bionic Pancreas | $77 |
| Beta Bionics | Meals · 2025-05-23 | Ilet Bionic Pancreas | $160 |
| Dexcom | Meals · 2025-05-14 | Dexcom G6 Transmitter | $21 |
| Lilly USA | Meals · 2025-05-09 | Mounjaro | $18 |
| Amgen | Meals · 2025-05-07 | Tepezza | $29 |
| Abbott Laboratories | Meals · 2025-04-21 | Freestyle Libre 3 | $16 |
| Lilly USA | Meals · 2025-04-16 | Mounjaro | $14 |
| Xeris Pharmaceuticals | Meals · 2025-03-28 | Recorlev | $19 |
| Tandem Diabetes Care | Meals · 2025-03-25 | T:Slim X2 Insulin Pump With Control-Iq | $18 |
| Amgen | Meals · 2025-03-12 | Tepezza | $26 |
| Xeris Pharmaceuticals | Meals · 2025-03-11 | Gvoke Hypopen | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-08 | Kerendia | $14 |
| Tandem Diabetes Care | Meals · 2025-02-28 | T:Slim X2 Insulin Pump With Control-Iq | $5 |
| Abbott Laboratories | Meals · 2025-02-24 | Freestyle Libre 3 | $15 |
| Abiomed | Meals · 2025-02-13 | None | $150 |
| Beta Bionics | Meals · 2025-02-08 | Ilet Bionic Pancreas | $10 |
| CeQur | Meals · 2025-02-07 | Cequr Simplicity | $178 |
| Medtronic | Meals · 2025-02-06 | Minimed 780g | $25 |
| Xeris Pharmaceuticals | Meals · 2025-01-17 | Recorlev | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,066
| Bayer Healthcare Pharmaceuticals | Kerendia | $215 | 10 payments
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $159 | 3 payments
|
| Xeris Pharmaceuticals | Gvoke Hypopen | $150 | 8 payments
|
| Lilly USA | Mounjaro | $94 | 4 payments
|
| Dexcom | Dexcom G6 Transmitter | $85 | 3 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $68 | 3 payments
|
| Medtronic | Minimed 780g | $67 | 3 payments
|
| Ascensia Diabetes Care Us | Eversense E3 Sensor Kit - Retail | $65 | 3 payments
|
| CeQur | Cequr Simplicity | $59 | 1 payment
|
| Astellas Pharma US | Veozah | $47 | 2 payments
|
| Novo Nordisk | Ozempic | $29 | 2 payments
|
| Amgen | Repatha | $28 | 1 payment
|
2023: $1,047
| CeQur | Cequr Simplicity | $283 | 1 payment
|
| Novo Nordisk | Ozempic | $143 | 10 payments
|
| W. L. Gore & Associates | Seamguard Staple Line Reinforcement | $120 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $114 | 3 payments
|
| Bigfoot Biomedical | Unity Diabetes Management System | $96 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $95 | 1 payment
|
| Amgen | Enbrel | $55 | 3 payments
|
| Lilly USA | Baqsimi | $33 | 2 payments
|
| Medtronic | Minimed 780g | $27 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $19 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $18 | 1 payment
|
| Supernus Pharmaceuticals | Tlando | $17 | 1 payment
|
| Sobi | Kineret | $14 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $14 | 1 payment
|
2022: $630
| Novo Nordisk | Saxenda | $192 | 9 payments
|
| CeQur | Cequr Simplicity | $155 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $125 | 1 payment
|
| Vifor Pharma | Veltassa | $51 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $24 | 1 payment
|
| Radius Health | Tymlos | $21 | 1 payment
|
| Tandem Diabetes Care | T:Slim X2 Insulin Pump With Control-Iq | $21 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $16 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 2 | $15 | 1 payment
|
| Xeris Pharmaceuticals | Recorlev | $12 | 1 payment
|
2021: $170
| Novo Nordisk | Ozempic | $128 | 9 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $24 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
2020: $46
| Novo Nordisk | None | $32 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $14 | 1 payment
|
2019: $209
| Radius Health | Tymlos | $122 | 1 payment
|
| Senseonics | Eversense | $43 | 2 payments
|
| Novo Nordisk | Tresiba | $31 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1700966652
- Licence
- CA C186416, PA MD432373California C186416: Current · expires 2027-05-31
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
- Mailing address
- 1926 Via Ctr Ste A, Vista, CA, 92081
- NPI first listed
- 2006-10-16
- NPI last updated
- 2024-05-22
- NPI record certified
- 2024-05-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5725 W Las Positas Blvd Ste 110, Pleasanton, CA, 94588
This office lists an electronic records connection.